Browsing by Author Lin, Benyao

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 20 of 32 next >
Issue Date Title Author(s)
2015 Association between CHEK2 H371Y mutation and response to neoadjuvant chemotherapy in women with breast cancer Liu, Yin;Xu, Ye;Ouyang, Tao;Li, Jinfeng;Wang, Tianfeng;Fan, Zhaoqing;Fan, Tie;Lin, Benyao;Xie, Yuntao
2018 Association between HER2 germline mutation A270S and prognosis in patients with primary breast cancer Si, Pilei;Xu, Ye;Ouyang, Tao;Li, Jinfeng;Wang, Tianfeng;Fan, Zhaoqing;Fan, Tie;Lin, Benyao;Xie, Yuntao
2015 Association between HER2 status and response to neoadjuvant anthracycline followed by paclitaxel plus carboplatin chemotherapy without trastuzumab in breast cancer Yao, Lu;Zhang, Juan;Liu, Yiqiang;Ouyang, Tao;Li, Jinfeng;Wang, Tianfeng;Fan, Zhaoqing;Fan, Tie;Lin, Benyao;Xie, Yuntao
2006 The association of CYP2D6 star 10 polymorphism with breast cancer risk and clinico-pathologic characteristics in Chinese women Li, Hongxia;Feng, Liya;Xu, Ye;Yao, Lihua;Ouyang, Tao;Li, Jinfeng;Wang, Tianfeng;Fan, Zhaoqing;Lin, Benyao;Li, Jiyou;Xie, Yuntao
2007 Association of p73 G4C14-to-A4T14 (GC/AT) polymorphism with breast cancer survival Li, Hongxia;Yao, Lihua;Tao Ouyang;Li, Jinfeng;Wang, Tianfeng;Fan, Zhaoqing;Fan, Tie;Dong, Bin;Lin, Benyao;Li, Jiyou;Xie, Yuntao
2015 Association of PIK3CA Mutation Status before and after Neoadjuvant Chemotherapy with Response to Chemotherapy in Women with Breast Cancer Yuan, Hua;Chen, Jiuan;Liu, Yiqiang;Ouyang, Tao;Li, Jinfeng;Wang, Tianfeng;Fan, Zhaoqing;Fan, Tie;Lin, Benyao;Xie, Yuntao
1-Jun-2020 BRCA1 c.5470_5477del, a founder mutation in Chinese Han breast cancer patients Meng, Hua;Yao, Lu;Yuan, Hua;Xu, Ye;Ouyang, Tao;Li, Jinfeng;Wang, Tianfeng;Fan, Zhaoqing;Fan, Tie;Lin, Benyao;Xie, Yuntao
2009 BRCA1 germline mutations and tumor characteristics in Chinese women with familial or early-onset breast cancer Chen, Weiqiu;Pan, Kaifeng;Ouyang, Tao;Li, Jinfeng;Wang, Tianfeng;Fan, Zhaoqing;Fan, Tie;Lin, Benyao;Lu, Youyong;You, Weicheng;Xie, Yuntao
2016 Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations Yao, Lu;Sun, Jie;Zhang, Juan;He, Yingjian;Ouyang, Tao;Li, Jinfeng;Wang, Tianfeng;Fan, Zhaoqing;Fan, Tie;Lin, Benyao;Xie, Yuntao
2015 Breast-conserving therapy and modified radical mastectomy for primary breast carcinoma: a matched comparative study Wang, Lize;Ouyang, Tao;Wang, Tianfeng;Xie, Yuntao;Fan, Zhaoqing;Lin, Benyao;Li, Jinfeng
2019 Co-mutation of TP53 and PIK3CA in residual disease after neoadjuvant chemotherapy is associated with poor survival in breast cancer Chen, Xinyi;Guo, Yonghai;Ouyang, Tao;Li, Jinfeng;Wang, Tianfeng;Fan, Zhaoqing;Fan, Tie;Lin, Benyao;Xu, Ye;Xie, Yuntao
23-Apr-2021 Comparison of Survival After Breast-Conserving Therapy vs Mastectomy Among Patients With or Without the BRCA1/2 Variant in a Large Series of Unselected Chinese Patients With Breast Cancer Wan, Qiting;Su, Liming;Ouyang, Tao;Li, Jinfeng;Wang, Tianfeng;Fan, Zhaoqing;Fan, Tie;Lin, Benyao;Xie, Yuntao
2016 Comprehensive analysis of BRCA1 and BRCA2 germline mutations in a large cohort of 5931 Chinese women with breast cancer Zhang, Juan;Sun, Jie;Chen, Jiuan;Yao, Lu;Ouyang, Tao;Li, Jinfeng;Wang, Tianfeng;Fan, Zhaoqing;Fan, Tie;Lin, Benyao;Xie, Yuntao
15-Jun-2020 Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers in a large cohort of unselected Chinese breast cancer patients Su, Liming;Xu, Ye;Ouyang, Tao;Li, Jinfeng;Wang, Tianfeng;Fan, Zhaoqing;Fan, Tie;Lin, Benyao;Xie, Yuntao
2009 Expression of ER-alpha 36, a Novel Variant of Estrogen Receptor alpha, and Resistance to Tamoxifen Treatment in Breast Cancer Shi, Liang;Dong, Bin;Li, Zhongwu;Lu, Yunwei;Tao Ouyang;Li, Jinfeng;Wang, Tianfeng;Fan, Zhaoqing;Fan, Tie;Lin, Benyao;Wang, Zhaoyi;Xie, Yuntao
2016 A genome-wide association study identifies WT1 variant with better response to 5-fluorouracil, pirarubicin and cyclophosphamide neoadjuvant chemotherapy in breast cancer patients Wu, Lina;Yao, Lu;Zhang, Hong;Ouyang, Tao;Li, Jinfeng;Wang, Tianfeng;Fan, Zhaoqing;Fan, Tie;Lin, Benyao;Yin, C. Cameron;Xie, Yuntao
2017 Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients Sun, Jie;Meng, Hua;Yao, Lu;Lv, Meng;Bai, Jian;Zhang, Jianguang;Wang, Lientu;Ouyang, Tao;Li, Jinfeng;Wang, Tianfeng;Fan, Zhaoqing;Fan, Tie;Lin, Benyao;Xie, Yuntao
2017 HER2 Pro1170Ala polymorphism is associated with decreased survival rate in HER2-negative breast cancer Si, Pilei;Xu, Ye;Ouyang, Tao;Li, Jinfeng;Wang, Tianfeng;Fan, Zhaoqing;Fan, Tie;Lin, Benyao;Xie, Yuntao
2017 HER2 somatic mutations are associated with poor survival in HER2-negative breast cancers Wang, Tonghui;Xu, Ye;Sheng, Shuyan;Yuan, Hua;Ouyang, Tao;Li, Jinfeng;Wang, Tianfeng;Fan, Zhaoqing;Fan, Tie;Lin, Benyao;Xie, Yuntao
Aug-2020 Impact of the addition of carboplatin to anthracycline-taxane-based neoadjuvant chemotherapy on survival inBRCA1/2-mutated triple-negative breast cancer Zhang, Juan;Yao, Lu;Liu, Yiqiang;Ouyang, Tao;Li, Jinfeng;Wang, Tianfeng;Fan, Zhaoqing;Fan, Tie;Lin, Benyao;Xie, Yuntao